Leveraging ‘Predictive Analytics to support Oncology Patient Journeys’
The oncology landscape is rapidly changing, with a significant surge in the number of approved therapies. In the past five years alone, 60+ new oncology drugs have been launched, intensifying competition among biopharmaceutical companies to effectively identify and engage specific patient segments that could benefit from these treatments. However, the challenge remains: how can companies
Read More